Primary Recipient

RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE

Amount

$79,350.00

Award Date

2/01/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

An emerging theme in experimental therapeutics concerns the use of glucagon-like peptide-1-(7-36)- amide (GLP-1) and its synthetic peptide analogs (the incretin mimetics) to lower levels of blood glucose in Type 2 diabetic subjects. This action of GLP-1 r